[Premenstrual syndrome--current approach].
Premenstrual syndrome (PMS) affects 3-5% of women. It still remains controversial in diagnosis and treatment. Dynamic progress in neuroendocrinology in recent years led to PMS etiology explanation. It also influenced therapeutic approach. According to Wang et al. neuroactive steroids and their imbalance evoke PMS symptoms. That theory introduced other therapeutic interventions restoring neuroendorine balance. The newer antidepresants demonstrated excellent efficacy in treatment of somatic and emotional PMS symptoms. PMS is a typical object of contemporary studies on therapeutic efficacy according to evidence based medicine.
Wiecheć
Marcin
M
Klinika Ginekologii i Niepłodności, Collegium Medicum, Uniwersytetu Jagiellońskiego w Krakowie. gyninf@mp.pl
Klimek
Marek
M
D005260:Female; D006801:Humans; D008019:Life Style; D011293:Premenstrual Syndrome / Q000145:classification / Q000175:diagnosis* / Q000628:therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D016387:Women's Health
D017367:Selective Serotonin Reuptake Inhibitors